ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 Nuclear Energy Conference & Expo (NECX)
August 24–27, 2026
Dallas, TX|Hilton Anatole
Latest Magazine Issues
Jul 2026
Jan 2026
2026
Latest Journal Issues
Nuclear Science and Engineering
September 2026
Nuclear Technology
August 2026
Fusion Science and Technology
Latest News
In transition: Commercializing fusion power
Commercial fusion power is closer than ever. There are now around 30 U.S. fusion companies, several of which claim to be on track to connect to the grid as early as the 2030s.
Tokamak and laser inertial confinement approaches benefit from decades of research at facilities such as the National Ignition Facility (NIF) at Lawrence Livermore National Laboratory and ITER, with alternative concepts including stellarator, magnetic mirror, and Z-pinch confinement also making notable progress as private and government funding for fusion increases.
G. S. Sidhu, W. E. Farley, L. F. Hansen, T. Komoto, B. Pohl, C. Wong
Nuclear Science and Engineering | Volume 63 | Number 1 | May 1977 | Pages 48-54
Technical Paper | doi.org/10.13182/NSE77-A27003
Articles are hosted by Taylor and Francis Online.
We have measured the spectra of neutrons and secondary gamma rays emerging from a liquid-nitrogen sphere of 129.3-cm radius with a 14-MeV neutron source at its center. Time-of-flight techniques were used to obtain the detailed data and to minimize background. To compare the measurements with calculations, we folded the detector efficiencies and appropriate experimental parameters into the calculated output of TARTNP, a coupled neutron-photon Monte Carlo transport code utilizing the Lawrence Livermore Laboratory Evaluated Neutron Data Library, September 1975. The calculated neutron spectra show fair agreement with the measurements, and the calculated gamma-ray spectrum is nearly the same as the corresponding measured spectrum. The total biological dose derived from these measurements is in good agreement with the calculations and provides a benchmark for a dose-versus-range curve obtained by TARTNP calculations.